New ultrasound technique could replace needle biopsy for liver disease
NCT ID NCT07588854
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a new endoscopic ultrasound method (EUS-SWQ) to measure liver stiffness and diagnose liver fibrosis (scarring) in people with chronic liver disease. Researchers will compare EUS-SWQ results with standard liver biopsy and FibroScan in 65 adults. The goal is to see if EUS-SWQ is accurate, safe, and easier for patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LIVER DISEASE (CLD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
RECRUITINGShanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a cholesterol drug and a bile acid pill help reverse liver scarring?
- Stick-On ultrasound patch could spot liver damage without a specialist
- Food flavors on the breath may reveal hidden liver disease
- New drug aims to halt liver scarring in early trial
- Could a vitamin d cocktail fix deficiency in kids with liver disease?
- Automated blood test strategy could spot hidden liver disease in routine checkups